Arvind Limited, ACT Grants to produce 30 M N95 masks in India

September 16, 2020 | Wednesday | News

The partnership is a response to PM Modi’s call to make wearing masks compulsory for the general public

Image source: Shutterstock

Image source: Shutterstock

Bengaluru based textile company Arvind Limited and ACT Grants have partnered to produce 30 million N95 masks in the next 12 months.

Arvind Limited has received a grant of Rs 100 million from ACT Grants, the non-profit coalition of VC funds and start-up founders, and will employ its manufacturing expertise on Medical Products and Working Capital to create a large, integrated facility for N95 mask production and distribution.

Arvind and ACT Grants will jointly donate 9 million masks over the next year to charitable institutions, government bodies, and other organizations, focusing on medical and non-medical professionals with the highest risk of contracting the virus.

The partnership is a swift response to PM Narendra Modi’s call to make wearing masks compulsory for the general public.  Upon complete scale-up, the daily N95 mask production capacity will be approximately 2 lakh units which would be operated, owned and managed by Arvind. This capacity would bridge the gap in supply and edge India towards self-sufficiency in N95 masks.

The N95 masks will be available through Arvind Advanced Material Distribution partners, direct sales channels to Government, hospitals, and other corporates. Arvind Advanced Materials is a large, pioneering manufacturer of PPE Coveralls and Face Masks which are certified by BIS and Global agencies. 

Apart from masks, Arvind also manufactures Protective Coveralls and Bio-Suits for medical practitioners and frontline warriors. Arvind has supplied more than 1 lakh coveralls so far to the Central and State Governments.

Comments

× Your session has expired. Please click here to Sign-in or Sign-up

Have an Account?

Forgot your password?

First Name should not be empty!

Last Name should not be empty!

Email address should not be empty!

Show Password should not be empty!

Show Confirm Password should not be empty!

Newsletter

E-magazine

Biospectrum Infomercial

Bio Resource

I accept the terms & conditions & Privacy policy